Antimalarial Adherence and Risk of Cardiovascular Events in Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients: A Population-based Study.
Md Rashedul HoqueJuan Antonio Aviña-ZubietaDiane LacailleMary A De VeraYi QianLawrence McCandlessJohn M EsdaileHui XiePublished in: Arthritis care & research (2023)
When people newly diagnosed with RA or SLE take their antimalarial regularly as prescribed (PDC≥0.90), they have 29% lower risk of sustaining a cardiovascular event than patients with a lower degree of adherence (PDC<0.90) and a 28% lower risk than if they discontinue antimalarials.